Bob G. Gower, Director at Ensysce Biosciences, Inc. (ENSC), bought 90,287 shares at $0.49 ($44K) on 2023-03-02, disclosed to the SEC on 2023-03-06.
Open-market purchase of $44k ENSC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ENSC | BUY | 2023-02-01 | $1.0M | — | Filing → |
| MILL | BUY | 2015-01-06 | $43K | — | Filing → |
| MILL | BUY | 2014-12-22 | $76K | — | Filing → |